NCT02549430 To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy Status COMPLETED Phase PHASE2
NCT02538484 Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects Status COMPLETED Phase EARLY_PHASE1
NCT02520063 Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02499146 Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT02491983 Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02482740 A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix Status UNKNOWN Phase PHASE2
NCT02457312 The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual Tissues Status COMPLETED Phase PHASE2
NCT02455154 Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy Status COMPLETED Phase PHASE2
NCT02450175 Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls Status UNKNOWN Phase NA
NCT02405156 Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion Status COMPLETED Phase PHASE2/PHASE3
NCT02401425 Use of Letrozole Pretreatment With Misoprostol for First-Trimester Medical Abortion Status COMPLETED Phase PHASE2/PHASE3
NCT02400567 Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women Status COMPLETED Phase PHASE2
NCT02389088 Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH. Status COMPLETED Phase NA
NCT02377479 Endocrinology Profile in Patients Undergoing Clomiphene, Letrozole, and Combination Clomiphene and Letrozole Cycles Status WITHDRAWN Phase NA
NCT02344550 Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02333370 A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT02313051 Everolimus trIal for Advanced prememopausaL Breast Cancer Patients Status UNKNOWN Phase PHASE2